Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$4.63 - $8.0 $0 - $0
0 New
0 $0
Q2 2022

Aug 01, 2022

SELL
$2.84 - $5.0 $2.26 Million - $3.98 Million
-796,458 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$13.56 - $18.48 $292,557 - $398,706
-21,575 Reduced 2.64%
796,458 $12.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
818,033
818,033 $11.4 Million

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $72.9M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Rho Capital Partners Inc Portfolio

Follow Rho Capital Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rho Capital Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Rho Capital Partners Inc with notifications on news.